TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 2.30E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan™) was used to measure the ability of the compound to compete for binding of an immobilized adenosin...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 5.10E+5nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan™) was used to measure the ability of the compound to compete for binding of an immobilized adenosin...More data for this Ligand-Target Pair
TargetVascular endothelial growth factor receptor 2(Homo sapiens (Human))
Kala Pharmaceuticals
US Patent
Kala Pharmaceuticals
US Patent
Affinity DataKd: 2.80E+3nMAssay Description:A competition binding assay (DiscoveRx KINOMEscan™) was used to measure the ability of the compound to compete for binding of an immobilized adenosin...More data for this Ligand-Target Pair